Skip to content

The Consolidation of Clinical Research Sites, Pt. 1

CRIO ebook: Scaling and Innovating - The Consolidation and Reinvention of Clinical Research Sites

In the rapidly evolving landscape of clinical research, site operations are undergoing a significant transformation. In this white paper, we will delve into a series of interviews with leading industry strategists. They’ll shed light on the necessary and long-term changes taking place.

Contributors and Their Insights:

We had the privilege of gathering insights from esteemed contributors who bring diverse perspectives to the table. David Blume, Edgemont Partners; Sean Stanton, founder of Compass Research; Dr. James Greenwald, Medex Healthcare Research (now IMA Research); Dr. Hans Hoeck, Trialcare; Dustin Caldwell, Optimed Research; Barry Lake, Devana Solutions; and Amanda Wright, Javara all shared their valuable perspectives.

A Necessary Transformation:

The industry is becoming increasingly complex and competitive. Sites need to evolve to meet the demands of sponsors, regulators, and patients. Consolidation will become an increasing trend to ensure the best-in-class quality of data collection, patient safety, and adherence to regulatory standards.

Challenges and Opportunities:

While the transformation towards digitization and scale brings significant opportunities, it also presents challenges. Contributors point out hurdles such as financial constraints, operational complexities, and the need for advanced technology and infrastructure. However, they also highlight the potential benefits, such as increased collaboration, knowledge sharing, and the ability to attract high-quality studies and sponsors.

The Path Forward:

To navigate this transformative journey successfully, the contributors stress the importance of strategic planning, partnerships, and embracing technological advancements. They recommend:

  • collaboration among sites
  • leveraging centralized platforms
  • implementing robust data management systems
  • and developing strong networks with sponsors, CROs, and other stakeholders


Altogether, this interview with leading strategists sheds light on the ongoing transformation of clinical research site operations towards professionalization and scale. While challenges lie ahead, the benefits of this consolidation are evident: improved quality, increased efficiency, and enhanced competitiveness. By embracing this transformation and adopting strategic approaches, clinical research sites can position themselves for long-term success in an ever-changing industry.

Next Steps:

Afterwards, catch up on the second part of this blog series where we explore the consolidation and reinvention of site networks, offering further insights into the evolving landscape of clinical research sites.

Related Reading: The Consolidation and Reinvention of Site Networks, Pt. 2

RaymondNomizu by Raymond Nomizu CEO at CRIO
Share this white paper
You may also find interesting
Explore our White Papers & eBooks
Clinical Trial Site Mega Network eBook
1 Minute Read -

The Rise of the Clinical Trial Site Mega Network

Discover our latest eBook, “The Rise of the Clinical Trial Site Mega Network” the third installment in our “Scaling and Innovating” series. The first book in this series was published in 2019, where CRIO predicted that clinical research site networks would continue to grow and consolidate the industry. The second eBook, which was published in...

Health Information & Clinical Research Integration: The Challenge
1 Minute Read -

Health Information & Clinical Research Integration: The Challenge

In the past several decades, Electronic Health Record (EHR) systems have become the standard in documenting clinical care in the United States and many other countries, while Electronic Data Capture (EDC) systems have become standard in global pharmaceutical trials. Naturally, the industry has been highly focused on the tantalizing possibility of integrating EHR into EDC....

A Comparison of EMR and eSource in Clinical Research Trials
1 Minute Read -

A Comparison of EMR and eSource Data

In a comparison of EMR and eSource data, we analyzed the medications and medical history documented in the EMR versus the EDC of subjects in active ongoing clinical research studies. The goal was to assess the validity of the assumption of the utility of using EMR data directly. The present study reveals a significant data...

Get articles delivered to your inbox, every week